周二，H.C. Wainwright调整了对外骨骼技术公司Ekso Bionics (NASDAQ:EKSO)的展望。该公司将其股票目标价从此前的$10.00下调至$9.00，但维持买入评级。这一调整是在Ekso Bionics周一公布第三季度财报后做出的，财报显示公司收入低于预期，每股净亏损也有所增加。 Ekso Bionics第三季度业绩显示，收入为$4.1 million，低于$5.5 mi ...

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

Ekso Bionics Holdings, Inc. (EKSO) 2024年第三季度业绩电话会：报告了410万美元的销售额，同比下降了10.87%，毛利润为220万美元，毛利率为53.5%，较去年同期的53.3%略有提升。公司在第三季度售出了33台EksoHealth设备，其中约半数销往欧洲和亚太地区。CEO Scott Davis强调了Ekso Indego ...

英为财情Investing.com - Ekso Bionics (NASDAQ: EKSO )星期一发布了第三季度的财报，数据显示，公司营收逊于分析师的预期，每股收益超出了分析师的预期。

Aixtream in VirtualRack supports Ferncast features and can integrate with other solutions via API. The companies said the ...

Analysts at HC Wainwright dropped their FY2026 earnings per share estimates for shares of Ekso Bionics in a research note ...

IRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes ...

Lake Street analyst Ben Haynor lowered the firm’s price target on Ekso Bionics (EKSO) to $2 from $2.50 and keeps a Buy rating on the ...

H.C. Wainwright lowered the firm’s price target on Ekso Bionics (EKSO) to $9 from $10 and keeps a Buy rating on the shares post the Q3 ...

Detailed price information for Ekso Bionics Holdings Inc (EKSO-Q) from The Globe and Mail including charting and trades.

Ekso Bionics Holdings, Inc. misses on earnings expectations. Reported EPS is $-0.10202 EPS, expectations were $-0.08.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. TipRanks is the most comprehensive data set of sell side ...